Cargando…
Enhancing Clinical Pharmacy Specialist Involvement in Transitions of Care Focusing on Ambulatory Care Sensitive Conditions within a Veterans Affairs Healthcare System
The purpose of this quality improvement project was to evaluate the impact of clinical pharmacy specialist (CPS) involvement in the post-discharge period on 30-day readmission rates within a Veterans Affairs Healthcare System. Patients eligible for inclusion were discharged from a Veterans Affairs (...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151698/ https://www.ncbi.nlm.nih.gov/pubmed/32235777 http://dx.doi.org/10.3390/pharmacy8010047 |
_version_ | 1783521309752295424 |
---|---|
author | Fisher, Morgan Cardoza, Amber Gordon, Autumn Howard, Molly Neighbors, Lynsey Ragan, Addison |
author_facet | Fisher, Morgan Cardoza, Amber Gordon, Autumn Howard, Molly Neighbors, Lynsey Ragan, Addison |
author_sort | Fisher, Morgan |
collection | PubMed |
description | The purpose of this quality improvement project was to evaluate the impact of clinical pharmacy specialist (CPS) involvement in the post-discharge period on 30-day readmission rates within a Veterans Affairs Healthcare System. Patients eligible for inclusion were discharged from a Veterans Affairs (VA) acute care facility with a principle or secondary diagnosis of heart failure (HF), chronic obstructive pulmonary disease (COPD), or both HF and COPD from 15 October 2018 through 14 January 2019. CPSs functioning as a mid-level provider with a scope of practice conducted telephone and in-clinic medication management appointments within 7 and 21 days post-discharge for qualifying patients discharged with a principle or secondary diagnosis of HF or COPD. CPS appointments focused on medication reconciliation, ensuring continuity of care, disease state counseling, and medication management. By enhancing the role of the CPS in the post-discharge period, there was an observed decrease in 30-day COPD index (p = 0.35), HF index (p = 0.23), and all-cause (p = 0.62) readmission rates from pre- to post-intervention. The results of this intervention show that CPS intervention in the post-discharge period may reduce index and all-cause readmission rates for patients discharged with a principle or secondary discharge diagnosis of COPD or HF. |
format | Online Article Text |
id | pubmed-7151698 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-71516982020-04-20 Enhancing Clinical Pharmacy Specialist Involvement in Transitions of Care Focusing on Ambulatory Care Sensitive Conditions within a Veterans Affairs Healthcare System Fisher, Morgan Cardoza, Amber Gordon, Autumn Howard, Molly Neighbors, Lynsey Ragan, Addison Pharmacy (Basel) Article The purpose of this quality improvement project was to evaluate the impact of clinical pharmacy specialist (CPS) involvement in the post-discharge period on 30-day readmission rates within a Veterans Affairs Healthcare System. Patients eligible for inclusion were discharged from a Veterans Affairs (VA) acute care facility with a principle or secondary diagnosis of heart failure (HF), chronic obstructive pulmonary disease (COPD), or both HF and COPD from 15 October 2018 through 14 January 2019. CPSs functioning as a mid-level provider with a scope of practice conducted telephone and in-clinic medication management appointments within 7 and 21 days post-discharge for qualifying patients discharged with a principle or secondary diagnosis of HF or COPD. CPS appointments focused on medication reconciliation, ensuring continuity of care, disease state counseling, and medication management. By enhancing the role of the CPS in the post-discharge period, there was an observed decrease in 30-day COPD index (p = 0.35), HF index (p = 0.23), and all-cause (p = 0.62) readmission rates from pre- to post-intervention. The results of this intervention show that CPS intervention in the post-discharge period may reduce index and all-cause readmission rates for patients discharged with a principle or secondary discharge diagnosis of COPD or HF. MDPI 2020-03-22 /pmc/articles/PMC7151698/ /pubmed/32235777 http://dx.doi.org/10.3390/pharmacy8010047 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Fisher, Morgan Cardoza, Amber Gordon, Autumn Howard, Molly Neighbors, Lynsey Ragan, Addison Enhancing Clinical Pharmacy Specialist Involvement in Transitions of Care Focusing on Ambulatory Care Sensitive Conditions within a Veterans Affairs Healthcare System |
title | Enhancing Clinical Pharmacy Specialist Involvement in Transitions of Care Focusing on Ambulatory Care Sensitive Conditions within a Veterans Affairs Healthcare System |
title_full | Enhancing Clinical Pharmacy Specialist Involvement in Transitions of Care Focusing on Ambulatory Care Sensitive Conditions within a Veterans Affairs Healthcare System |
title_fullStr | Enhancing Clinical Pharmacy Specialist Involvement in Transitions of Care Focusing on Ambulatory Care Sensitive Conditions within a Veterans Affairs Healthcare System |
title_full_unstemmed | Enhancing Clinical Pharmacy Specialist Involvement in Transitions of Care Focusing on Ambulatory Care Sensitive Conditions within a Veterans Affairs Healthcare System |
title_short | Enhancing Clinical Pharmacy Specialist Involvement in Transitions of Care Focusing on Ambulatory Care Sensitive Conditions within a Veterans Affairs Healthcare System |
title_sort | enhancing clinical pharmacy specialist involvement in transitions of care focusing on ambulatory care sensitive conditions within a veterans affairs healthcare system |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151698/ https://www.ncbi.nlm.nih.gov/pubmed/32235777 http://dx.doi.org/10.3390/pharmacy8010047 |
work_keys_str_mv | AT fishermorgan enhancingclinicalpharmacyspecialistinvolvementintransitionsofcarefocusingonambulatorycaresensitiveconditionswithinaveteransaffairshealthcaresystem AT cardozaamber enhancingclinicalpharmacyspecialistinvolvementintransitionsofcarefocusingonambulatorycaresensitiveconditionswithinaveteransaffairshealthcaresystem AT gordonautumn enhancingclinicalpharmacyspecialistinvolvementintransitionsofcarefocusingonambulatorycaresensitiveconditionswithinaveteransaffairshealthcaresystem AT howardmolly enhancingclinicalpharmacyspecialistinvolvementintransitionsofcarefocusingonambulatorycaresensitiveconditionswithinaveteransaffairshealthcaresystem AT neighborslynsey enhancingclinicalpharmacyspecialistinvolvementintransitionsofcarefocusingonambulatorycaresensitiveconditionswithinaveteransaffairshealthcaresystem AT raganaddison enhancingclinicalpharmacyspecialistinvolvementintransitionsofcarefocusingonambulatorycaresensitiveconditionswithinaveteransaffairshealthcaresystem |